Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Renal Insufficiency × Bortezomib × Clear all

Phase

Phase 2 7 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 4 Renal Insufficiency 1 Primary Myelofibrosis 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia 1 Breast Neoplasms 1

Interventions

Dexamethasone 1 Cyclophosphamide 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06142396 2026-03-12

Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure

Augusta University

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡